Last reviewed · How we verify
Multiple ascending doses SUL-238
At a glance
| Generic name | Multiple ascending doses SUL-238 |
|---|---|
| Sponsor | GEN İlaç ve Sağlık Ürünleri A.Ş. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |